Skip to the reading A question kit for finding care First read Take-along questions Wordbook Sermorelin Before the visit Guidebook menu Start here What sermorelin is Questions people bring Check the clinician Check the pharmacy Choose a visit setting Understand the rules Weigh the research Ask about the bill Prepare for a visit Plan tests and follow-up Spot reasons to pause Talk through possible harms Take-along questions Look up a word Read the source notes Bring a question. Expect a clear answer. # Read the support, and the limits beside it. The useful part of a source is what it can answer. Keep the study, the approval record, and the licensing record in their own places. Evidence The record offered to support a claim; ask what it actually measured or decided. What approval history can tell you Evidence to keep in view The old approval and its ending The Food and Drug Administration (FDA) record describes sermorelin (Geref, discontinued) as a hormone test and a treatment for childhood growth problems. The approvals ended on June 18, 2009; the FDA’s March 2013 finding about why Geref left the market did not restore them. Read the FDA history and withdrawal finding Read the withdrawal notice When someone cites a past approval, ask which use it covered and whether that is the use being proposed to you. Sermorelin acetate The chemical form in the former drug; compounding means making a medicine to order. What a pharmacy route can tell you Evidence to keep in view Compounding has conditions Reading the ordinary-pharmacy rules as of September 28, 2026, points to a possible route for sermorelin acetate when all conditions are met. No FDA ordinary-pharmacy document found in that review names sermorelin; the conditional reading does not approve a finished product. Read the FDA ordinary-pharmacy guidance Read the FDA outsourcing category document Read the FDA compounding questions and answers Ask which route the maker relies on. Keep the pharmacy name and the explanation together. What a study can tell you Evidence to keep in view Adult studies leave large questions open Each adult study in this review included 10 to 19 participants, with a duration of 16 weeks at most. A modified relative of sermorelin was used in the Khorram study; across the studies measuring body fat, that measure stayed unchanged. Read the Corpas adult study Read the Vittone adult study Read the Khorram adult study A study link deserves a specific follow-up: which finding supports the benefit you are describing to me? What a public record can tell you State medical boards publish physician license information and the discipline each state makes public. Find the appropriate medical board → The FDA links to state pharmacy license searches. Find a state pharmacy search → A license record cannot promise the quality of an individual assessment or prescription. Use the sources to sharpen the question you ask, not to settle your own diagnosis. Return to the take-along questions → This guide helps you question a sermorelin care offer; operating clinics and selling medicines are outside its role. Keep the questions handy Check the sources Untangle a word Open the plain-text version of this page